Metall Zug (XSWX:METN) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XSWX:METN Metall Zug Ltd XSWX:METN
56 GF Score
Price CHF827.00
GF Value CHF762.94
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Metall Zug FFO?

FFO (Funds from operations) only applies to REITs.

XSWX:METN
56GF Score
Metall Zug Ltd XSWX:METN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Metall Zug (XSWX:METN) Overvalued in 2026?

Based on GuruFocus' analysis, Metall Zug stock appears to be overvalued. The current stock price of CHF827.00 is trading 8.4% above its estimated GF Value™ of CHF762.94. GuruFocus considers Metall Zug to be Fairly Valued.

Key valuation signals for XSWX:METN:

  • FFO:
  • GF Value™: CHF762.94 vs. price of CHF827.00 (8.4% above fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the XSWX:METN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Metall Zug Business Description

Other Exchanges 0QLX:UKNDH1:Germany
Address Industriestrasse 66, Zug, CHE, 6302
Metall Zug Ltd is engaged in the industrial sector. The company is organized, into business segments namely; Medical Devices which comprises of products and services for diagnosis and surgery, mainly in the fields of ophthalmology and microsurgery; Technologycluster & Infrastructure is engaged in Management and development of real estate; and Investments & Corporate. The majority of its revenue is generated from the Medical Devices segment. Geographically, the company operates in Switzerland, Europe (excluding Switzerland), the Americas, and Asia /Pacific/Others, and the majority of its revenue is generated from the Americas region.
56GF Score

Get the complete analysis for XSWX:METN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

CHF827.00
Price
CHF762.94
GF Value